Plasma adiponectin is associated with ankle-brachial index in patients on haemodialysis

Nephrology

Volumn 12, Issue 6, 2007, Pages 546-552

  Lim, Paik Seong ^a,b,c   Hu, Chuen Yuh ^a   Wu, Ming Ying ^a   Wu, Tsai Kun ^a   Chang, Hui Chen ^a  

^a TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^b PROVIDENCE UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Adiponectin; Ankle brachial index; Haemodialysis; Peripheral arterial disease

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANKLE; BRACHIAL ARTERY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 35948973604     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00839.x     Document Type: Article

References (42)

1. U.S. Renal Data System. USRDS 1998 Annual Data Report. Bethesda, MD : National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, 1998.
2. O'Hare AM, Johansen KL. Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2001 12 : 2838 47.
3. Lim PS, Chen TT, Yang SM, Chien SW, Kuo YC, Tsai Pai MA. Prevalence and clinical correlates of peripheral arterial disease in hemodialysis patients. Acta Nephrologica 2005 19 : 113 20.
4. Testa A, Ottavioli JN. Ankle-arm blood pressure index (AABPI) in hemodialysis patients. Arch. Mal. Coeur Vaiss. 1998 91 : 963 5.
5. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am. J. Kidney Dis. 1996 27 : 668 72.
6. Ono K, Tsuchida A, Kawai H et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J. Am. Soc. Nephrol. 2003 14 : 1591 8.
7. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 2002 13 : 51 9.
8. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999 257 : 79 83.
9. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad. Sci. 1999 892 : 146 54.
10. Weyer C, Funahashi T, Tanaka S. et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol Metab. 2001 86 : 930 35.
11. Iwashima Y, Katsuya T, Ishikawa K et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004 43 : 1318 23.
12. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000 20 : 1595 9.
13. Kumada M, Kihara S, Sumitsuji S et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 85 9.
14. Kistorp C, Faber J, Galatius S et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005 112 : 1756 62.
15. Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001 103 : 1057 63.
16. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999 100 : 2473 6.
17. Shoji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 2002 61 : 2187 92.
18. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: Is a higher cholesterol level better for atherosclerosis in uremia? Am. J. Kidney Dis. 2001 38 (4 Suppl 1 S4 7.
19. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 2002 13 (1 134 41.
20. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function. Am. J. Kidney Dis. 2004 43 (6 1047 55.
21. Selvin E, Erlinger TP. Prevalence and risk factors for peripheral arterial disease in the US: Results from the National Health and Nutrition Examination Survey (NHANES). 1999-2000. Circulation 2004 110 : 738 43.
22. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 (Suppl 1 S5 20.
23. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486.
24. Eggers PW, Gohdes D, Pugh J. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int. 1999 56 : 1524 33.
25. Premalatha G, Shanthirani S, Deepa R., MarkovitZ. J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population - The Chennai Urban Population Study (CUPS). Diabetes Care. 2000 23 : 1295 300.
26. Cui R., Iso H, Yamagishi K et al. Ankle-arm blood pressure index and cardiovascular risk factors in elderly Japanese men. Hypertens Res. 2003 26 : 377 82.
27. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilaon PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am. Heart J. 2002 143 : 961 5.
28. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001 285 : 2481 5.
29. Hozawa A, Ohmori K, Kurimaya S. C-Reactive protein and peripheral artery disease among Japanese elderly: The Tsurugaya Project. Hypertens Res. 2004 27 : 955 61.
30. Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW. Hyperhomocysteinemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am. J. Kidney Dis. 1999 34 : 669 77.
31. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999 55 : 1899 911.
32. Iwashima Y, Horio T, Suzuki Y et al. Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 2006 188 (2 384 90.
33. Dieplinger B, Poelz W, Haltmayer M, Mueller T. Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease. Clin. Chem. Laboratory Med. 2006 44 (7 830 3.
34. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin. Chim. Acta 2004 344 : 1 12.
35. Jansson PA, Pellme F, Hammarstedt A et al. A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J. 2003 17 : 1434 40.
36. Gil-Campos M, Cañete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin. Nutr. 2004 23 : 963 74.
37. Guebre-Egziabher F, Bernhard J, Geelen G, Malvoisin E, Hadj-Aissa A, Fouque D. Leptin, adiponectin, and ghrelin dysregulation in chronic kidney disease. J Ren Nutr. 2005 15 : 116 20.
38. Arita Y, Kihara S, Ouchi Y et al. Adipocyte-derived plasma protein, adiponectin, acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002 105 : 2893 8.
39. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women <62 years of age. Am. J. Cardiol. 1994 74 : 64 5.
40. Newby DE, Wright RA, Labinjoh C et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction. Circulation 1999 99 : 1411 5.
41. Gil-Nunez AC, Vivancos-Mora J. Blood pressure as a risk factor for stroke and the impact of antihypertensive treatment. Cerebrovasc. Dis. 2005 20 (Suppl 2 40 52.
42. Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy. Nephrology 2006 11 : 36 41.